EBR Systems Future Growth
Future criteria checks 2/6
EBR Systems's earnings are forecast to decline at 5.7% per annum while its annual revenue is expected to grow at 84.8% per year. EPS is expected to grow by 13.5% per annum.
Key information
-5.7%
Earnings growth rate
13.5%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 84.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 04 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 13 | -40 | -42 | -42 | 1 |
| 12/31/2025 | 9 | -41 | -41 | -39 | 2 |
| 12/31/2024 | 0 | -39 | -38 | -37 | 2 |
| 12/31/2023 | N/A | -35 | -33 | -33 | N/A |
| 9/30/2023 | N/A | -34 | -32 | -32 | N/A |
| 6/30/2023 | N/A | -33 | -31 | -31 | N/A |
| 3/31/2023 | N/A | -33 | -31 | -30 | N/A |
| 12/31/2022 | N/A | -33 | -31 | -30 | N/A |
| 9/30/2022 | N/A | -36 | -30 | -29 | N/A |
| 6/30/2022 | N/A | -40 | -29 | -28 | N/A |
| 3/31/2022 | N/A | -40 | -26 | -25 | N/A |
| 12/31/2021 | N/A | -40 | -23 | -22 | N/A |
| 9/30/2021 | N/A | -33 | -19 | -18 | N/A |
| 6/30/2021 | N/A | -25 | -15 | -15 | N/A |
| 3/31/2021 | N/A | -26 | -17 | -16 | N/A |
| 12/31/2020 | N/A | -26 | -18 | -18 | N/A |
| 12/31/2019 | 1 | -25 | -21 | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EBR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EBR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EBR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EBR's revenue (84.8% per year) is forecast to grow faster than the Australian market (4.7% per year).
High Growth Revenue: EBR's revenue (84.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EBR's Return on Equity is forecast to be high in 3 years time